SCHEMBL963193

SCHEMBL963193

CC1COC(C)C[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8574825 1.00
SCHEMBL2437440 1.00
SCHEMBL8318230 1.00
SCHEMBL3496163 0.71
Propylene Oxide SCHEMBL187161 0.71
SCHEMBL10871904 0.71
Propylene Oxide SCHEMBL1292008 0.71
Propylene Oxide SCHEMBL65104 0.71
Propylene Oxide SCHEMBL2711413 0.71
SCHEMBL409272 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110020277-A1 Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-01-27 US claimed
US-4758564-A Ether and thioether amines and their use as fungicides BASF AKTIENGESELLSCHAFT (DE) 1988-07-19 US claimed
US-11053215-B2 Heterocyclic compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2021-07-06 US disclosed
US-10450296-B2 Heterocyclic compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2019-10-22 US disclosed
US-20180282302-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2018-10-04 US disclosed
US-9920032-B2 Heterocyclic compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-03-20 US disclosed
US-20170096411-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-04-06 US disclosed
EP-2547684-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES University of Basel (CH) 2013-01-23 EP disclosed
WO-2011114275-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES UNIVERSITY OF BASEL (CH) 2011-09-22 WO disclosed
EP-0447947-A1 N-(3-Phenyl-2-methylpropyl and -methyl-prop-2-enyl)-azaheterocycles BASF Aktiengesellschaft (DE) 1991-09-25 EP disclosed